-
Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories
PRNewswire
March 19, 2020
Eli Lilly and Company announced today its scientists are partnering with the Indiana State Department of Health (ISDH), with support from the Food and Drug Administration (FDA), to accelerate testing in Indiana for SARS-CoV-2, the virus that causes COVID-
-
Latest developments in epidemic control on March 18 (2)
chinadaily
March 18, 2020
WUHAN — Here are the latest developments on the novel coronavirus disease (COVID-19) in China
-
Latest developments in epidemic control on March 18(1)
chinadaily
March 18, 2020
WUHAN — Here are the latest developments on the novel coronavirus disease (COVID-19) in China.
-
COVID-19: The immune system can fight back
worldpharmanews
March 18, 2020
Melbourne researchers have mapped immune responses from one of Australia's first novel coronavirus (COVID-19) patients, showing the body's ability to fight the virus and recover from the infection.
-
Novartis announces broad range of initiatives to respond to COVID-19 Pandemic; Creates USD 20 million global fund to support impacted communities
worldpharmanews
March 18, 2020
Novartis announced a broad set of measures to support the global response to the COVID-19 pandemic.
-
Emergent BioSolutions Initiates Development of Plasma-Derived Candidates Coronavirus
americanpharmaceuticalreview
March 18, 2020
Emergent BioSolutions has initiated development of two product candidates for the treatment and prevention of coronavirus disease (COVID-19).
-
CEPI calls for $2bn of funding for coronavirus vaccine
europeanpharmaceuticalreview
March 18, 2020
According to CEPI, $2 billion is needed to progress coronavirus vaccines through development as quickly as possible, leading the organisation to call for donations.
-
Roche Ships First 400,000 COVID-19 Tests
contractpharma
March 18, 2020
Labs across U.S. to begin patient testing under FDA Emergency Use Authorization.
-
BioNTech signs Covid-19 vaccine deals with Pfizer and Fosun
pharmaceutical-technology
March 18, 2020
German biotechnology firm BioNTech has partnered with Pfizer to jointly develop and distribute a potential mRNA-based Covid-19 vaccine.
-
First US clinical trial of Covid-19 vaccine candidate begins
pharmaceutical-technology
March 18, 2020
The first US clinical trial of a Covid-19 vaccine candidate, which is Moderna’s mRNA-1273, has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.